These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12546343

  • 1. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA, Williams P, Walker JC.
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [Abstract] [Full Text] [Related]

  • 2. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T, Costa V, Silva I, Oliva T, Norton L.
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [Abstract] [Full Text] [Related]

  • 3. Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
    Oulego-Erroz I, Maneiro-Freire M, Bouzón-Alejandro M, Vázquez-Donsión M, Couselo JM.
    Pediatr Blood Cancer; 2010 Sep; 55(3):557-9. PubMed ID: 20533520
    [Abstract] [Full Text] [Related]

  • 4. Management and successful desensitization in methotrexate-induced anaphylaxis.
    Bouchireb K, Dodille A, Ponvert C, Gouraud F, Dubrel M, Brugières L.
    Pediatr Blood Cancer; 2009 Feb; 52(2):295-7. PubMed ID: 18855892
    [Abstract] [Full Text] [Related]

  • 5. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K, Matsuoka H, Murakami T, Fujimoto T, Takayanagi F, Sawai K, Niwa J, Hara K.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [Abstract] [Full Text] [Related]

  • 6. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma.
    Postovsky S, Ben Arush MW.
    Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003
    [Abstract] [Full Text] [Related]

  • 7. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
    Pugi A, Benemei S, Vietri M, Tondo A, Calvani AM, Mugelli A, Vannacci A, Lapi F.
    J Clin Pharm Ther; 2012 Apr; 37(2):245-8. PubMed ID: 21569069
    [Abstract] [Full Text] [Related]

  • 8. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G, Ferrari S, Longhi A, Forni C, Loro L, Beghelli C, Tremosini M, Versari M.
    Oncol Rep; 2003 Apr; 10(4):851-7. PubMed ID: 12792734
    [Abstract] [Full Text] [Related]

  • 9. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
    Broome CB, Schiff RI, Friedman HS.
    Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
    [Abstract] [Full Text] [Related]

  • 10. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S, Orlandi M, Avella M, Caldora P, Ferraro A, Ravazzolo G, Bacci G.
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [Abstract] [Full Text] [Related]

  • 11. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR, Liu T, Rodriguez-Galindo C, Tan M, Meyer WH, Panetta JC, Link MP, Daw NC.
    Cancer; 2004 Apr 15; 100(8):1724-33. PubMed ID: 15073863
    [Abstract] [Full Text] [Related]

  • 12. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G, Loro L, Longhi A, Bertoni F, Bacchini P, Versari M, Picci P, Serra M.
    Anticancer Drugs; 2006 Apr 15; 17(4):411-5. PubMed ID: 16549998
    [Abstract] [Full Text] [Related]

  • 13. [The importance of dose intensity in preoperative chemotherapy for osteosarcoma--retrospective analysis of a short intensive chemotherapy regimen preoperatively using high-dose methotrexate and cisplatinum].
    Takahashi M, Katagiri H, Sato K, Sugiura H, Yamamura S, Fukaya N, Nakanishi K.
    Gan To Kagaku Ryoho; 1994 Mar 15; 21(4):459-64. PubMed ID: 8129386
    [Abstract] [Full Text] [Related]

  • 14. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
    Yamada K, Takahashi M, Yoshida M.
    Gan To Kagaku Ryoho; 2002 Mar 15; 29(3):469-72. PubMed ID: 11915742
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T, Takada N, Hodaka E, Endoh F, Ishii T.
    Gan To Kagaku Ryoho; 1984 Feb 15; 11(2):285-94. PubMed ID: 6582805
    [Abstract] [Full Text] [Related]

  • 16. Anaphylactoid reactions to methotrexate.
    Alkins SA, Byrd JC, Morgan SK, Ward FT, Weiss RB.
    Cancer; 1996 May 15; 77(10):2123-6. PubMed ID: 8640680
    [Abstract] [Full Text] [Related]

  • 17. [Desensitization protocol to methotrexate. Clinical case].
    Maya-Epelstein J, Morales A, Del-Rio-Navarro B, Rosas-Vargas MÁ.
    Rev Alerg Mex; 2012 May 15; 59(4):214-7. PubMed ID: 24008032
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups.
    J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977
    [Abstract] [Full Text] [Related]

  • 19. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
    Delepine N, Delepine G, Bacci G, Rosen G, Desbois JC.
    Cancer; 1996 Nov 15; 78(10):2127-35. PubMed ID: 8918406
    [Abstract] [Full Text] [Related]

  • 20. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N, Jost W, Müller J, Keller HE, Sitzmann FC.
    Klin Padiatr; 1990 Nov 15; 202(5):340-6. PubMed ID: 2214594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.